News

Acadia Pharmaceuticals Inc. announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug…
Read More...

Poseida Therapeutics, Inc. announced it has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to…
Read More...

Sinovac Biotech Ltd. announced that based on related clinical trials and studies of vaccination for local children and adolescents, the Health Bureau of the Government of the Hong Kong…
Read More...

Radiopharm Theranostics, a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that it has entered a…
Read More...

Kiniksa Pharmaceuticals, Ltd. announced a global license agreement with Roche and Genentech, a member of the Roche Group (Genentech), for the rights to develop and commercialize…
Read More...

Sosei Group Corporation announce they have entered a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules that…
Read More...

Rigel Pharmaceuticals, Inc. and Forma Therapeutics, Inc. announced that they have entered into an exclusive, worldwide license agreement to develop, manufacture and commercialize…
Read More...

Synthego announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by providing arrayed CRISPR-edited cells for direct use in functional…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Biotia, Inc., a company that…
Read More...

TransCode Therapeutics, Inc. the RNA oncology company, and The University of Texas MD Anderson Cancer Center (“MD Anderson”), announced a strategic alliance to advance TransCode’s…
Read More...

Gamida Cell Ltd.  announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s Biologics License Application (BLA) for omidubicel for the treatment…
Read More...

Xeris Biopharma Holdings, Inc. announced that Tetris Pharma—its commercialization partner for Ogluo in the UK, EEA, and Switzerland—will be acquired by Arecor Therapeutics (AIM: AREC),…
Read More...

Krystal Biotech, Inc. announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate KB407 in a clinical…
Read More...

GreenLight Biosciences and Samsung Biologics announced the successful completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Since…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved STELARA (ustekinumab) for the treatment of…
Read More...

GreenLight Biosciences has announced a collaboration with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and…
Read More...

Novartis and the University of California, Berkeley have extended their research-based collaboration to develop new technologies for the discovery of next-generation therapeutics,…
Read More...

Melinta Therapeutics, LLC and Cidara Therapeutics announced that they have entered into a License Agreement to facilitate a strategic partnership to commercialize rezafungin, a novel,…
Read More...

Novavax, Inc. announced that Nuvaxovid COVID-19 vaccine received expanded manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for primary…
Read More...

AbbVie announced the European Commission (EC) approved RINVOQ (upadacitinib 45 mg and 15 mg and 30 mg ) for the treatment of adult patients with moderately to severely active…
Read More...